HomeACQUISITIONS and MERGERS

ACQUISITIONS and MERGERS

Wave Neuroscience Acquires Assets of NeoSync

In addition, Wave Neuroscience has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Boston Scientific expects to complete the transaction in the first half of 2024, subject to customary closing conditions.

E Tech Group Announces Brand Name Change of Recently Acquired System Integrator, E-Volve Systems

E Tech Group announces the immediate renaming of E-Volve Systems to E Tech Group, following their strategic acquisition on February 23, 2023, emphasizing a unified vision, expanded services, and enhanced client and market value through this integration.

Allentown LLC Announces the Acquisition of ClorDiSys

ClorDiSys is a family-owned and operated company that began in 2001 as a decontamination equipment provider but quickly added surface-top disinfection products, as well as on-site decontamination services to its portfolio to better address customer challenges

TekniPlex Healthcare Acquires Seisa Medical

Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.

Stryker Announces Intent to Acquire SERF SAS, Enhancing Its Global Joint Replacement Leadership

SERF SAS is recognized by healthcare professionals worldwide for its innovations in hip implants, including the invention of the original Dual Mobility Cup.

Lunit to Acquire Volpara: Scheme Implementation Agreement Signed

Following the decision, Lunit and Volpara have entered into a Scheme Implementation Agreement, under which Lunit will acquire all of Volpara's shares at a price of AUD 1.15 per share through a New Zealand scheme of arrangement (Scheme).

Imbio to be Acquired by 4DMedical Creating Comprehensive Cardiothoracic Image Analysis Portfolio

"Imbio is very excited to join forces with 4DMedical to create the leading lung imaging AI suite in the market, combining 4DMedical's functional analysis with Imbio's anatomical and tissue analysis. Together we can help clinicians around the globe detect disease earlier, make more robust diagnosis, and drive more informed and confident decision-making for better patient care," said Dave Hannes, CEO at Imbio.

Supercell Acquires Exclusive Licensing from Japanese Immunotherapy Leader for Advanced NK Cell Treatment Technology

Supercell, through partnerships in regenerative medicine, has secured an exclusive license for a Japanese-developed natural killer (NK) cell culture technique. The technique, pivotal in cancer cell elimination and immune system enhancement, will be showcased at the expo, highlighting their latest experimental advancement.